Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Anti-virus {virus COVID-19}: Yes! Were used to Resolve it as a Cancer Problem. It Works for Ebola

*Corresponding Author:

Copyright: © 2020  . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 
To read the full article Peer-reviewed Article PDF image

Abstract

When viruses infect host cells or organs, the dysfunction of these parts (or tumors) is a result. We name it “a tumor” then we tackle it as a cancer issue! Very straightforward: it works for Ebola.

We have options in oncology: Surgery, Radiation, Chemotherapy, and Immunotherapy. Depending on the rate of its spread, we use one or a combination of those treatments. The rate of success depends on the stage (spread of tumors).

Infection with COVID-19 often causes a severe acute respiratory syndrome. We could consider it as a lung cancer, and treatment plans for it are already well-established in the field of oncology. It’s a virus, so the patient should be considered a candidate for treatment with immunotherapy (or vaccines) based on our body’s defense against cancer.

Keywords

Recommended Conferences
Google Scholar citation report
Citations : 58

Advances in Cancer Prevention received 58 citations as per Google Scholar report

Indexed In
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Euro Pub
  • ICMJE
Share This Page
Top